U.S. flag An official website of the United States government.
Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

i

The Mainstreaming Addiction Treatment Act and Pharmacist-Prescribed Buprenorphine.

Supporting Files
File Language:
English


Details

  • Alternative Title:
    JAMA, 2025, v. 334, no. 3: The Mainstreaming Addiction Treatment Act and Pharmacist-Prescribed Buprenorphine.
  • Journal Article:
    JAMA
  • Personal Author:
    Tran, Emmy L. ; Rikard, S. Michaela ; Guy, Gery P. ; Mikosz, Christina A
  • Description:
    The number of prescribers of buprenorphine for opioid use disorder (OUD) is limited, which might hinder access to treatment.1 The Mainstreaming Addiction Treatment (MAT) Act, effective December 2022, aimed to increase buprenorphine access by removing federal requirements for clinicians to obtain a Drug Addiction Treatment Act (DATA) waiver to prescribe buprenorphine for OUD.2 Previously, pharmacists could only prescribe buprenorphine through a collaborative practice agreement with DATA-waivered clinicians; the MAT Act now allows pharmacists to prescribe buprenorphine directly or via a collaborative practice agreement, though states may still have specific restrictive criteria for pharmacist prescribing.3 This study examines the impact of the MAT Act on trends in pharmacist-prescribed buprenorphine from 2019 to 2024. Results were examined overall and by patient age and sex given documented differences in buprenorphine dispensing by patient demographics
  • Content Notes:
    Author manuscript
  • Subjects:
  • Source:
    JAMA, 2025, v. 334, no. 3
  • DOI:
    https://doi.org/10.1001/jama.2025.7151
  • ISSN:
    0098-7484 ; 1538-3598
  • Pubmed ID:
    40522675
  • Pubmed Central ID:
    PMC13007967
  • Document Type:
    Text
  • Funding:
    CC999999/ImCDC/Intramural CDC HHSUnited States/
  • Genre:
    Journal Article
  • Pages in Document:
    269-271 (5 pdf pages)
  • Volume:
    334
  • Issue:
    3
  • Download URL:
    https://stacks.cdc.gov/view/cdc/261327/cdc_261327_DS1.pdf
  • File Type:
    Filetype[PDF - 337.32 KB]
  • Collection(s):
    CDC Public Access
  • Main Document Checksum:
    urn:sha-512:ab51a22895c2da13196acb264e579d0ce9d4901fbe8be9d37f61e653edf4d71fcc09426e24a08cb7ed68da006e6c172c65dc87fbec278f1d55d336d7e3987d86
PREVIOUS
File Language:
English
ON THIS PAGE
Details Supporting Files
 Was this page helpful?
 Found an issue?
Send us an email at:
publishinghd@cdc.gov
CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners.

As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
BACK TO TOP